Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20102
20121
20131
20151
20161
20182
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status3
Recruiting2
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Traws Pharma, Inc.3
Assistance Publique - Hôpitaux de Paris2
Groupe Francophone des Myelodysplasies2
Celgene1
Incyte Corporation1
Saint-Louis Hospital, Paris, France1
Taiho Oncology, Inc.1
University Hospital, Bordeaux1
University Hospital, Grenoble1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts18
Myelodysplastic Syndromes12
Leukemia, Myelomonocytic, Chronic5
Leukemia3
Anemia, Refractory2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid, Acute2
Anemia1
Anemia, Sickle Cell1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.